Sing2016 M2SR H3N2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sing2016 M2SR H3N2, covering 2022-03-04 to 2022-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of the Bris10 M2SR and Sing2016 M2SR H3N2 Monovalent Influenza Vaccines [Phase 1]